High Court Blocks US Plan To Base Ebola Quarantine Facility In Kenya
The High Court in Nairobi has temporarily blocked the government from establishing or operationalizing a controversial, United States-funded Ebola quarantine and treatment facility on Kenyan soil.
In a decisive late-night ruling on Thursday, May 28, 2026, High Court Judge Patricia Nyaundi issued sweeping conservatory orders freezing the bilateral agreement and strictly barring the entry, transfer, or reception of any foreign nationals exposed to or infected with the lethal virus. The judicial intervention lands a major blow to a fast-tracked White House plan to isolate exposed American citizens in Africa rather than flying them back to the United States.
A “Secretive and Unilateral” Containment Deal
The legal battle was triggered by governance and human rights watchdog Katiba Institute, which filed an urgent petition challenging the lack of transparency surrounding the multi-billion shilling biological defense deal.
The lawsuit followed formal announcements from senior Trump administration officials stating that a 50-bed tactical isolation facility—located at the Laikipia Air Base in Nanyuki—was structurally complete and ready to become operational. The U.S. State Department had pledged KSh 1.74 billion ($13.5 million) toward Kenya’s broader epidemic readiness, a deal cemented during a direct phone call between President William Ruto and U.S. Secretary of State Marco Rubio.
However, the Katiba Institute argued that the executive branch overstepped its constitutional mandate by turning the country into an “offshore containment colony” for a foreign superpower trying to insulate its own borders.
“The secretive, unilateral establishment of an Ebola quarantine facility raises grave constitutional concerns regarding the rights to life, health, fair administrative action, public participation, and parliamentary oversight,” the rights group stated in its submissions.
Kenya Lacks Level 4 Bio-Containment Capabilities
A central pillar of the legal challenge focused on Kenya’s severe infrastructure limitations regarding Level 4 pathogens. In the supporting affidavit sworn by Katiba Institute Executive Director Nora Mbagathi, the court was warned that Kenya’s current laboratory and medical networks are predominantly limited to Biosafety Level 1 (BSL-1) and BSL-2, with only a nominal number of BSL-3 facilities.
The petition emphasized that Kenya completely lacks the hyper-secure BSL-4 containment infrastructure mandatory for handling the highly infectious Bundibugyo Ebola strain, which currently has zero approved vaccines or clinical treatments.
Allowing potentially infected individuals into an unequipped domestic military base, the petitioner argued, posed an “imminent and catastrophic risk” to local health workers and the broader public under Articles 26 (Right to Life) and 43 (Right to Health) of the Constitution.
African Health Authorities and Unions Applaud Halt
The High Court’s injunction has been met with widespread relief from the domestic medical community and regional health bodies, who had fiercely condemned the executive’s agreement with Washington.
Dr. Davji Atellah, Secretary General of the Kenya Medical Practitioners, Pharmacists and Dentists Union (KMPDU), had previously issued a strike warning, declaring, “If it is too dangerous for America, it is too dangerous for Kenya.”
Internationally, Dr. Jean Kaseya, head of the Africa Centers for Disease Control and Prevention (Africa CDC), had also raised red flags, warning that forcing an international quarantine burden onto Kenya would severely fracture the nation’s fragile healthcare ecosystem.
Justice Nyaundi ruled that public interest heavily favored the preservation of constitutional accountability and national biosecurity over diplomatic expediency. The state, represented by the Attorney General and the Cabinet Secretary for Health, has been restrained from executing any facet of the foreign program until an inter-partes hearing takes place, which the court scheduled for June 2, 2026
